Cyclooctane containing seal swelling compositions and methods for use of same
12503662 ยท 2025-12-23
Assignee
Inventors
- Mukund Karanjikar (Salt Lake City, UT, US)
- Robert Andrew Price (Salt Lake City, UT, US)
- Oyvind Hatlevik (Holladay, UT, US)
- Michael James Mella (South Jordan, UT, US)
Cpc classification
C10L10/00
CHEMISTRY; METALLURGY
International classification
Abstract
A method for use of seal swelling compositions includes receiving a composition including one or more compounds according to formula (I), wherein each R independently represents a hydrogen atom or an alkyl group; and applying the composition to a first number of elastomeric seals to facilitate swelling of the first number of elastomeric seals.
Claims
1. A method for use of seal swelling compositions comprising: receiving a composition including one or more compounds according to formula (I), wherein each R independently represents a hydrogen atom or an alkyl group ##STR00008## and applying the composition to a first number of elastomeric seals to facilitate swelling of the first number of elastomeric seals.
2. The method of claim 1, wherein the first number of elastomeric seals are positioned in a fuel system.
3. The method of claim 1, wherein the composition is mixed with one or more fuel compositions selected from the group consisting of synthetic paraffinic kerosene (SPK), Jet-A fuel, HEFA, HEFA-Jet and L-Jet.
4. The method of claim 2, wherein the fuel system is a component of an internal combustion engine including a second number of elastomeric seals.
5. The method of claim 4, further comprising injecting the composition into the internal combustion engine to facilitate swelling of the second number of elastomeric seals.
6. The method of claim 1, wherein the one or more compounds according to formula (I) comprise one or more of a following compounds: ##STR00009##
7. The method of claim 1, wherein the composition further comprises one or more compounds having one of following structures: ##STR00010##
8. The method of claim 1, wherein the composition is free of aromatic compounds.
9. The method of claim 1, wherein the composition is free of petroleum-based compounds.
10. The method of claim 1, wherein the composition comprises one or more petroleum-based compounds.
11. The method of claim 1, wherein the composition comprises between about 1% and about 100% by weight of the one or more compounds according to formula (I).
12. The method of claim 1, wherein the composition comprises between about 50% to and about 99% by weight of the one or more compounds according to formula (I).
13. An elastomeric seal, comprising a body configured to expand from a first configuration having a first volume to a second configuration having a second volume larger than the first volume in response to exposure to a composition including one or more compounds according to formula (I) ##STR00011## wherein each R independently represents a hydrogen atom or an alkyl group.
14. The elastomeric seal of claim 13, wherein the one or more compounds according to formula (I) comprise one or more of a following compounds: ##STR00012##
15. The elastomeric seal of claim 13, wherein the composition further comprises one or more compounds having one of following structures: ##STR00013##
16. The elastomeric seal of claim 13, wherein the composition is free of aromatic compounds.
17. The elastomeric seal of claim 13, wherein the composition is free of petroleum-based compounds.
18. The elastomeric seal of claim 13, wherein the composition comprises one or more petroleum-based compounds.
19. The elastomeric seal of claim 13, wherein the composition is positioned in a fuel system.
20. The elastomeric seal of claim 19, wherein the fuel system is a component of an internal combustion engine.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) For the purpose of illustrating the invention, the drawings show aspects of one or more embodiments of the invention. However, it should be understood that the present invention is not limited to the precise arrangements and instrumentalities shown in the drawings, wherein:
(2)
(3)
(4)
(5)
(6)
(7)
(8) The drawings are not necessarily to scale and may be illustrated by phantom lines, diagrammatic representations, and fragmentary views. In certain instances, details that are not necessary for an understanding of the embodiments or that render other details difficult to perceive may have been omitted. Like reference symbols in the various drawings indicate like elements.
DETAILED DESCRIPTION
(9) Aspects of the present disclosure may be related to compositions for swelling an elastomeric seal and to uses of the same. Aspects of the present disclosure may be used to compositions which include one or more cyclooctane compounds and the use thereof to induce swelling of an elastomeric seal when the elastomeric seal is exposed to the composition. Aspects of the present disclosure may be used to reduce the dependence on fossil fuels and mitigate the negative environmental impacts thereof. Exemplary embodiments illustrating aspects of the present disclosure are described below in the context of several specific examples.
(10) In an embodiment, a composition includes one or more compounds according to formula (I)
(11) ##STR00003##
where each R independently represents a hydrogen atom or an or an alkyl group.
(12) Regarding one or more compounds of formula (I), a non-limiting method of preparation includes reacting a conjugated diene, or a mixture of conjugated dienes, with a catalyst selected from the group consisting of: a low-valent iron catalyst stabilized with a pyridineimine ligand; an iron precatalyst coordinated to a pyridineimine ligand and activated with a reducing agent; a low oxidation state iron complex stabilized with a pyridineimine ligand and a coordinating ligand; and combinations thereof, thereby forming a substituted cyclooctadiene. The reaction is carried out under an inert atmosphere, optionally using the diene as both solvent and reactant, at a temperature ranging from about 80 C. to about 100 C., for a duration of about 1 to 48 hours. In various embodiments, the molar ratio of diene to catalyst ranges from about 100:1 to about 1,000,000:1, and is approximately 4,000:1 in a specific example. More particular but non-limiting compounds according to formula (I) which may be included in the compositions described herein, either alone or in some combination, include the following:
(13) ##STR00004##
These compounds may include (1R,4S)-1,4-dimethylcyclooctane, (1S,4S)-1,4-dimethylcyclooctane, (1s,5s)-1,5-dimethylcyclooctane, (1r,5r)-1,5-dimethylcyclooctane. DMCO may be used herein to refer to any of these compounds individually or to any combination thereof. These compounds may be prepared in accordance with the following reaction scheme:
(14) ##STR00005##
In an embodiment, a method may be provided for producing a 1,4-dimethylcyclooctane (DMCO) from isoprene through an iron-catalyzed hydrogenation process. In this reaction scheme, isoprene may undergo dimerization and subsequent hydrogenation in the presence of an iron-based catalyst under hydrogenation conditions to form DMCO. In an embodiment, isoprene starting material may include a mixture of isoprene monomers obtained from renewable or petrochemical feedstocks. During the hydrogenation step, a catalyst comprising iron, optionally with supporting ligands, may be exposed to hydrogen to promote the conversion of isoprene to DMCO with controlled selectivity. As a side product, a hydrogenated isoprene dimers (HID) fraction may be formed, comprising a range of saturated C10 cycloalkane isomers. In an embodiment, HID fraction may include 1-isopropyl-4-methylcyclohexane, 1-ethyl-1,4-dimethylcyclohexane, 1-isopropyl-2-methylcyclohexane and other branched cycloalkanes. In this reaction scheme, HID is representative of hydrogenated isoprene dimers (HID) which are also a product of the reaction scheme, and HID may also include about 10% to about 15% by weight of DMCO. HID may additionally or alternatively be representative of compounds having one of the following structures:
(15) ##STR00006##
In one or more embodiment, HIDs may include (1s,4s)-1-isopropyl-4-methylcyclohexane (1), (1s,4s)-1-ethyl-1,4-dimethylcyclohexane (2), (1S,3R)-1-isopropyl-3-methylcyclohexane (3), (1S,3S)-1-isopropyl-3-methylcyclohexane (4), (1r,4r)-1-ethyl-1,4-dimethylcyclohexane (5), (1r,4r)-1-isopropyl-4-methylcyclohexane (6), (1R,3S)-1-ethyl-1,3-dimethylcyclohexane (7), (1R,3R)-1-ethyl-1,3-dimethylcyclohexane (8). In some forms, the compositions described herein may include one or more of the compounds represented by HID.
(16) In one or more embodiments, one or more composition may include one or more n-alkanes, one or more iso-alkanes, or a mixture of one or more n-alkanes and one or more iso-alkanes. When a mixture of one or more n-alkanes and one or more iso-alkanes is included, the one or more n-alkanes and one or more iso-alkanes may include those found in hydrogen processed esters and fatty acid compositions known as hydroprocessed esters and fatty acids (HEFA) or HEFA-Jet. In one or more embodiments, various embodiments of HEFA may include HEFA-SPK (Hydroprocessed Esters and Fatty Acids-Synthetic Paraffinic Kerosene), and HVO (Hydrotreated Vegetable Oil). However, the inclusion of additional and/or alternative n-alkanes and/or iso-alkanes may also be possible and contemplated. In some forms, the n-alkane may include n-decane, the iso-alkane may include iso-decane, and the mixture may include n-decane and iso-decane not limiting examples of which include 2-methyl nonane, 3-methyl nonane, 4-methyl nonane, 2,2-dimethyl octane, 3,3-dimethyl octane, 4,4-dimethyl octane, 2,3-dimethyl octane, 2,4-dimethyl octane, 2,5-dimethyl octane, 2,6-dimethyl octane, 2,7-dimethyl octane, 3,4-dimethyl octane, 3,5-dimethyl octane, 3,6-dimethyl octane, 2,2,3-trimethyl heptane, 2,2,4-trimethyl heptane, 2,2,5-trimethyl heptane, 2,2,6-trimethyl heptane, 2,3,3-trimethyl heptane, 2,3,4-trimethyl heptane, 2,3,5-trimethyl heptane, 2,3,6-trimethyl heptane, 3,3,4-trimethyl heptane, 2,2,3,3-tetramethyl hexane, 2,2,4,4-tetramethyl hexane, 2,2,5,5-tetramethyl hexane, 2,3,3,4-tetramethyl hexane, 2,3,3,5-tetramethyl hexane, 2,3,4,5-tetramethyl hexane, 2,2,3,3,4-pentamethyl pentane and 2,2,3,4,4-pentamethyl pentane.
(17) In one or more embodiments, an amount of one or more compounds according to formula (I) and at least one n-alkane, at least one iso-alkane or the mixture thereof may be varied depending on various properties of the one or more compounds according to formula (I) and at least one n-alkane, at least one iso-alkane or a mixture thereof as necessary to provide a composition with desired properties or characteristics such as density or derived cetane number.
(18) In one or more embodiments, one or more compounds according to formula (I) may be present at about 1% to about 100% by weight based on a total weight of a composition. However, other variations may be contemplated and possible. For example and without limitation, one or more compounds according to formula (I) may be present at about 2% to about 99% by weight based on a total weight of the composition, at about 5% to about 95% by weight based on a total weight of the composition, at about 10% to about 90% by weight based on a total weight of a total weight of the composition, at about 20% to about 85% by weight based on a total weight of the composition, at about 25% to about 80% by weight based on a total weight of the composition, at about 30% to about 70% by weight based on a total weight of the composition, at about 40% to about 60% by weight based on a total weight of the composition, at about 50% to about 99% by weight based on a total weight of the composition, at about 33% to about 66% by weight based on a total weight of the composition, or in any range defined by one or more of these values.
(19) In one or more embodiments, compositions including one or more compounds according to formula (I) as described herein may induce swelling of an elastomeric seal when the elastomeric seal is exposed to the composition. In one or more embodiments, elastomeric seal may include but are not limited to nitrile rubber (NBR), fluorosilicone rubber, fluoroelastomers, acrylate-based elastomers (O-rings), additive-manufactured (AM) elastomers (acrylate/dimethacrylate).
(20) To facilitate the understanding of this invention, a number of terms are defined below and throughout the disclosure. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology herein is used to describe specific embodiments of the invention, but their usage does not limit the invention, except as outlined in the claims.
(21) It is understood that the acts described below are meant as a general overview and demonstration of an exemplary method, and that the method may include different and/or additional acts as described herein or otherwise.
(22) While the present invention will be described as having particular configurations disclosed herein, the present invention can be further modified within the spirit and scope of this disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the invention using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this invention pertains.
(23) It is to be understood that any aspect and/or element of any embodiment of the method(s) described herein or otherwise may be combined in any way to form additional embodiments of the method(s) all of which are within the scope of the method(s).
(24) Where a process is described herein, those of ordinary skill in the art will appreciate that the process may operate without any user intervention. In another embodiment, the process includes some human intervention (for example, a step is performed by or with the assistance of a human).
(25) For the purposes of this disclosure, including the claims, the phrase at least some means one or more and includes the case of only one. Thus, for example, the phrase at least some ABCs means one or more ABCs and includes the case of only one ABC.
(26) For the purposes of this disclosure, including the claims, the term at least one should be understood as meaning one or more and therefore includes both embodiments that include one or multiple components. Furthermore, dependent claims that refer to independent claims that describe features with at least one have the same meaning, both when the feature is referred to as the and the at least one.
(27) For the purposes of this disclosure, the term portion means some or all. Therefore, for example, A portion of X may include some of X or all of X. In the context of a conversation, the term portion means some or all of the conversation.
(28) For the purposes of this disclosure, including the claims, the phrase using means using at least and is not exclusive. Thus, for example, the phrase using X means using at least X. Unless specifically stated by use of the word only, the phrase using X does not mean using only X.
(29) For the purposes of this disclosure, including the claims, the phrase based on means based in part on or based, at least in part, on and is not exclusive. Thus, for example, the phrase based on factor X means based in part on factor X or based, at least in part, on factor X. Unless specifically stated by use of the word only, the phrase based on X does not mean based only on X.
(30) In general, for the purposes of this disclosure, including the claims, unless the word only is specifically used in a phrase, it should not be read into that phrase.
(31) For the purposes of this disclosure, including the claims, the phrase distinct means at least partially distinct. Unless specifically stated, distinct does not mean fully distinct. Thus, for example, the phrase X is distinct from Y means that X is at least partially distinct from Y and does not mean that X is fully distinct from Y. Thus, for the purposes of this disclosure, including the claims, the phrase X is distinct from Y means that X differs from Y in at least some way.
(32) It should be appreciated that the words first, second, and so on, in the description and claims, are used to distinguish or identify, and not to show a serial or numerical limitation.
(33) Similarly, letter labels (for example, (A), (B), (C), and so on, or (a), (b), and so on) and/or numbers (for example, (i), (ii), and so on) are used to assist in readability and to help distinguish or identify, and are not intended to be otherwise limiting or to impose or imply any serial or numerical limitations or orderings. Similarly, words such as particular, specific, certain, and given, in the description and claims, if used, are to distinguish or identify, and are not intended to be otherwise limiting.
(34) For the purposes of this disclosure, including the claims, the terms multiple and plurality mean two or more, and include the case of two. Thus, for example, the phrase multiple ABCs means two or more ABCs and includes two ABCs. Similarly, for example, the phrase multiple PQRs means two or more PQRs and includes two PQRs.
(35) The present invention also covers the exact terms, features, values, and ranges, etc., in case these terms, features, values, and ranges, etc., are used in conjunction with terms such as about, around, generally, substantially, essentially, at least, etc. Thus, for example, about 3 or approximately 3 shall also cover exactly 3, and substantially constant shall also cover exactly constant.
(36) For the purposes of this disclosure, unless stated otherwise, the terms about or approximately refer to a value that is within 10% above or below the value being described.
(37) For the purposes of this disclosure, including the claims, singular forms of terms are to be construed as also including the plural form and vice versa, unless the context indicates otherwise. Thus, it should be noted that for the purposes of this disclosure, the singular forms a, an, and the include plural references unless the context clearly dictates otherwise. In other words, terms such as a, an, and the are not intended to refer to only a singular entity but include the general class of which a specific example may be used for illustration.
(38) Throughout the description and claims, the terms comprise, including, having, contain, and their variations should be understood as meaning including but not limited to and are not intended to exclude other components unless specifically so stated.
(39) It will be appreciated that variations to the embodiments of the invention can be made while still falling within the scope of the invention. Alternative features serving the same, equivalent, or similar purpose can replace features disclosed in the specification, unless stated otherwise. Thus, unless stated otherwise, each feature disclosed represents one example of a generic series of equivalent or similar features.
(40) Use of exemplary language, such as for instance, such as, for example (e.g.,) and the like, is merely intended to better illustrate the invention and does not indicate a limitation on the scope of the invention unless specifically so claimed.
(41) While the invention has been described in connection with what is presently considered to be the most practical and embodiments thereof are further described in the examples below, it is to be understood that the invention is not to be limited to the disclosed embodiment, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims.
(42) The following description sets forth various examples along with specific details to provide a thorough understanding of claimed subject matter. It will be understood by those skilled in the art, however, that claimed subject matter may be practiced without one or more of the specific details disclosed herein. Further, in some circumstances, well-known methods, procedures, systems, and/or components have not been described in detail in order to avoid unnecessarily obscuring claimed subject matter. The illustrative embodiments described in the detailed description and claims are not meant to be limiting. Other embodiments may be utilized, and other changes may be made, without departing from the spirit or scope of the subject matter presented here. It will be readily understood that the aspects of the present disclosure, as generally described herein, can be arranged, substituted, combined, and designed in a wide variety of different configurations, all of which are explicitly contemplated and make part of this disclosure.
Definitions
(43) Definitions of specific functional groups and chemical terms are described in more detail below. For purposes of this invention, the chemical elements are identified in accordance with the Periodic Table of the Elements, Chemical Abstracts Service (CAS) version of the periodic table of the elements, Handbook of Chemistry and Physics, 106th Ed., inside cover, and specific functional groups are generally defined as described therein. Additionally, general principles of organic chemistry, as well as specific functional moieties and reactivity, are described in Organic Chemistry, Thomas Sorrell, 2nd Edition, University Science Books, 2006; Smith, March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 9th Edition, Wiley, 2025; Larock, Comprehensive Organic Transformations, 3rd Edition, Wiley, 2018; Carruthers and Coldham, Modern Methods of Organic Synthesis, 4th Edition, Cambridge University Press, Cambridge, 2004.
(44) The term, alkyl, as used herein, refers to saturated, straight- or branched-chain hydrocarbon radicals derived from a hydrocarbon moiety containing between one and twenty carbon atoms by removal of a single hydrogen atom. In some embodiments, the alkyl group employed in the invention contains 1-20 carbon atoms (C1-20 alkyl). In another embodiment the alkyl group contains 1-15 carbon atoms (C1-15 alkyl), in another embodiment the alkyl group contains 1-10 carbon atoms (C1-10 alkyl). In another embodiment the alkyl group contains 1-8 carbon atoms (C1-8 alkyl). In another embodiment the alkyl group contains 1-6 carbon atoms (C1-6 alkyl). In another embodiment the alkyl group contains 1-5 carbon atoms (C1-5 alkyl). In another embodiment the alkyl group contains 1-4 carbon atoms (C1-4 alkyl). In another embodiment the alkyl group contains 1-3 carbon atoms (C1-3 alkyl). In another embodiment, the alkyl group contains 1-2 carbon atoms (C1-2 alkyl), with examples of alkyl radicals including, but not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, n-pentyl, neopentyl, n-hexyl, sec-hexyl, n-heptyl, n-octyl, n-decyl, n-undecyl, dodecyl, and the like, which may bear one or more substituents, and alkyl group substituents include, but are not limited to, any of the substituents described herein that result in the formation of a stable moiety. The term alkylene, as used herein, refers to a biradical derived from an alkyl group as defined herein by removal of two hydrogen atoms. An alkylene group may be cyclic or acyclic. It may also be branched or unbranched. An alkylene group may be substituted or unsubstituted. Substituents on the alkylene group may include, but are not limited to, any of the substituents described herein that result in the formation of a stable moiety.
(45) The term, aryl, as used herein, refers to an aromatic mono- or polycyclic ring system having 3-20 ring atoms, of which all the ring atoms are carbon, and which may be substituted or unsubstituted. In certain embodiments of the present invention, aryl refers to a mono, bi, or tricyclic C4-C20 aromatic ring system having one, two, or three aromatic rings which include, but are not limited to, phenyl, biphenyl, naphthyl, and the like, which may bear one or more substituents. Aryl substituents include, but are not limited to, any of the substituents described herein, that result in the formation of a stable moiety.
(46) The term, arylene, as used herein refers to an aryl biradical derived from an aryl group, as defined herein, by removal of two hydrogen atoms. Arylene groups may be substituted or unsubstituted. Arylene group substituents include, but are not limited to, any of the substituents described herein, that result in the formation of a stable moiety. Additionally, arylene groups may be incorporated as a linker group into an alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, or heteroalkynylene group, as defined herein.
(47) The term, heteroaryl, as used herein, refers to an aromatic mono- or polycyclic ring system having 3-20 ring atoms, of which one ring atom is selected from S, O, and N; zero, one, or two ring atoms are additional heteroatoms independently selected from S, O, and N; and the remaining ring atoms are carbon, the radical being joined to the rest of the molecule via any of the ring atoms. Exemplary heteroaryls include, but are not limited to pyrrolyl, pyrazolyl, imidazolyl, pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazinyl, tetrazinyl, pyyrolizinyl, indolyl, quinolinyl, isoquinolinyl, benzoimidazolyl, indazolyl, quinolinyl, isoquinolinyl, quinolizinyl, cinnolinyl, quinazolynyl, phthalazinyl, naphthridinyl, quinoxalinyl, thiophenyl, thianaphthenyl, furanyl, benzofuranyl, benzothiazolyl, thiazolynyl, isothiazolyl, thiadiazolynyl, oxazolyl, isoxazolyl, oxadiaziolyl, oxadiaziolyl, and the like, which may bear one or more substituents. Heteroaryl substituents include, but are not limited to, any of the substituents described herein, that result in the formation of a stable moiety.
(48) The term, heteroarylene, as used herein, refers to a biradical derived from an heteroaryl group, as defined herein, by removal of two hydrogen atoms. Heteroarylene groups may be substituted or unsubstituted. Additionally, heteroarylene groups may be incorporated as a linker group into an alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, or heteroalkynylene group, as defined herein. Heteroarylene group substituents include, but are not limited to, any of the substituents described herein, which result in the formation of a stable moiety.
(49) At a high level, aspects of the present disclosure are directed to cyclooctane containing seal swelling composition and methods for use of same.
(50) Aspects of the present disclosure can be used as a method for use of seal swelling compositions including one or more compounds according to formula (I), wherein each R independently represents a hydrogen atom or an alkyl group; and applying the composition to a first number of elastomeric seals to facilitate swelling of the first number of elastomeric seals.
(51) Aspects of the present disclosure can be used to an elastomeric seal includes a body configured to expand from a first configuration having a first volume to a second configuration having a second volume larger than the first volume in response to exposure to a composition including one or more compounds according to formula (I), wherein each R independently represents a hydrogen atom or an alkyl group.
(52) Exemplary embodiments illustrating aspects of the present disclosure are described below in the context of several specific examples.
(53) Referring now to
(54) Referring now to
(55) ##STR00007##
where each R independently represents a hydrogen atom or an or an alkyl group. In one or more embodiments, formula (I) may include (1R,4S)-1,4-dimethylcyclooctane, (1S,4S)-1,4-dimethylcyclooctane, (1s,5s)-1,5-dimethylcyclooctane, (1r,5r)-1,5-dimethylcyclooctane.
(56) With continued reference to
(57) With continued reference to
(58) With continued reference to
(59) With continued reference to
(60) With continued reference to
(61) With continued reference to
(62) With continued reference to
(63) Referring now to
(64) Referring now to
(65) Referring now to
(66) With continued reference to
(67) Referring now to
(68) With continued reference to
(69) In some forms, a composition including one or more compounds according to formula (I) may be mixed with one or more fuel compositions before being added to the fuel system 200 and/or the internal combustion engine 300. These fuel compositions may include synthetic paraffinic kerosene (SPK), Jet-A fuel, hydrogen processed esters and fatty acid compositions known as HEFA or HEFA-Jet, and/or L-Jet, just to provide a few non-limiting examples. Alternatively, in some forms, a composition including one or more compounds according to formula (I) may be added to the fuel system 200 and/or the internal combustion engine 300 as a separate seal-swelling additive.
(70) In some forms, the compositions described herein may be entirely or substantially free of any petroleum-based or petroleum-derived compounds, although forms in which petroleum-based or petroleum-derived compounds are present are contemplated and possible. In some forms, the compositions described herein may be entirely or substantially free of any aromatic compounds, although forms in which aromatic compounds are present are contemplated and possible.
(71) Referring now to
(72) Referring now to
(73) With continued reference to
(74) Referring now to
EXAMPLES
(75) The following examples are intended to be illustrative of the disclosure only and are not intended to limit the scope or underlying principles in any way.
(76) Different compositions including one or more compounds according to formula (I) as described herein were tested for effectiveness to provide swelling of nitrile rubber seals. More specifically, effectiveness for DMCO compositions referred to as H15 and H233 for swelling a nitrile rubber seal was tested. The H15 and H233 compositions were tested at different concentrations in an admixture with Jet-A or alone relative to the effectiveness of Jet-A alone and the seal swelling effectiveness range of conventional jet fuel. The different compositions were tested in a manner similar to that set forth in Section 2.2 of Measurements of Nitrile Rubber Absorption of Hydrocarbons: Trends for Sustainable Aviation Fuel Compatibility by Faulhaber et al., Bioenergy, Biofuels, and Biorefinery, Jun. 7, 2023. The results of the testing are graphically illustrated in